These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 26304236)

  • 21. Anaphase catastrophe is a target for cancer therapy.
    Galimberti F; Thompson SL; Ravi S; Compton DA; Dmitrovsky E
    Clin Cancer Res; 2011 Mar; 17(6):1218-22. PubMed ID: 21288923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NF-κB induces abnormal centrosome amplification by upregulation of CDK2 in laryngeal squamous cell cancer.
    Liu JL; Ma HP; Lu XL; Sun SH; Guo X; Li FC
    Int J Oncol; 2011 Oct; 39(4):915-24. PubMed ID: 21769424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of UGT1A1 and CYP2B6 by an antimitogenic factor in HepG2 cells is mediated through suppression of cyclin-dependent kinase 2 activity: cell cycle-dependent expression.
    Sugatani J; Osabe M; Kurosawa M; Kitamura N; Ikari A; Miwa M
    Drug Metab Dispos; 2010 Jan; 38(1):177-86. PubMed ID: 19797611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The development of a CDK2-docking site peptide that inhibits p53 and sensitizes cells to death.
    Ferguson M; Luciani MG; Finlan L; Rankin EM; Ibbotson S; Fersht A; Hupp TR
    Cell Cycle; 2004 Jan; 3(1):80-9. PubMed ID: 14657672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CEP78 functions downstream of CEP350 to control biogenesis of primary cilia by negatively regulating CP110 levels.
    Gonçalves AB; Hasselbalch SK; Joensen BB; Patzke S; Martens P; Ohlsen SK; Quinodoz M; Nikopoulos K; Suleiman R; Damsø Jeppesen MP; Weiss C; Christensen ST; Rivolta C; Andersen JS; Farinelli P; Pedersen LB
    Elife; 2021 Jul; 10():. PubMed ID: 34259627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclin-dependent kinase 2 (Cdk2) is required for centrosome duplication in mammalian cells.
    Matsumoto Y; Hayashi K; Nishida E
    Curr Biol; 1999 Apr; 9(8):429-32. PubMed ID: 10226033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fate of pancreatic tumor cell lines following p16 overexpression depends on the modulation of CDK2 activity.
    Calbó J; Serna C; Garriga J; Graña X; Mazo A
    Cell Death Differ; 2004 Oct; 11(10):1055-65. PubMed ID: 15309028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells.
    Akiyama T; Yoshida T; Tsujita T; Shimizu M; Mizukami T; Okabe M; Akinaga S
    Cancer Res; 1997 Apr; 57(8):1495-501. PubMed ID: 9108451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27.
    Vlach J; Hennecke S; Amati B
    EMBO J; 1997 Sep; 16(17):5334-44. PubMed ID: 9311993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preventing the degradation of mps1 at centrosomes is sufficient to cause centrosome reduplication in human cells.
    Kasbek C; Yang CH; Yusof AM; Chapman HM; Winey M; Fisk HA
    Mol Biol Cell; 2007 Nov; 18(11):4457-69. PubMed ID: 17804818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E.
    Cheng PH; Rao XM; McMasters KM; Zhou HS
    PLoS One; 2013; 8(2):e57340. PubMed ID: 23437375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adhesion-dependent control of cyclin E/cdk2 activity and cell cycle progression in normal cells but not in Ha-ras transformed NRK cells.
    Carstens CP; Krämer A; Fahl WE
    Exp Cell Res; 1996 Nov; 229(1):86-92. PubMed ID: 8940252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of Cdk2 activity decreases Aurora-A kinase centrosomal localization and prevents centrosome amplification in breast cancer cells.
    Leontovich AA; Salisbury JL; Veroux M; Tallarita T; Billadeau D; McCubrey J; Ingle J; Galanis E; D'Assoro AB
    Oncol Rep; 2013 May; 29(5):1785-8. PubMed ID: 23446853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5.
    Meijer L; Borgne A; Mulner O; Chong JP; Blow JJ; Inagaki N; Inagaki M; Delcros JG; Moulinoux JP
    Eur J Biochem; 1997 Jan; 243(1-2):527-36. PubMed ID: 9030781
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the melanoma cell cycle and regulation at the G1/S transition by 12-O-tetradecanoylphorbol-13-acetate (TPA) by modulation of CDK2 activity.
    Coppock DL; Buffolino P; Kopman C; Nathanson L
    Exp Cell Res; 1995 Nov; 221(1):92-102. PubMed ID: 7589260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation.
    Hydbring P; Bahram F; Su Y; Tronnersjö S; Högstrand K; von der Lehr N; Sharifi HR; Lilischkis R; Hein N; Wu S; Vervoorts J; Henriksson M; Grandien A; Lüscher B; Larsson LG
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):58-63. PubMed ID: 19966300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lovastatin mediated G1 arrest in normal and tumor breast cells is through inhibition of CDK2 activity and redistribution of p21 and p27, independent of p53.
    Rao S; Lowe M; Herliczek TW; Keyomarsi K
    Oncogene; 1998 Nov; 17(18):2393-402. PubMed ID: 9811471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CP110 cooperates with two calcium-binding proteins to regulate cytokinesis and genome stability.
    Tsang WY; Spektor A; Luciano DJ; Indjeian VB; Chen Z; Salisbury JL; Sánchez I; Dynlacht BD
    Mol Biol Cell; 2006 Aug; 17(8):3423-34. PubMed ID: 16760425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cep97 and CP110 suppress a cilia assembly program.
    Spektor A; Tsang WY; Khoo D; Dynlacht BD
    Cell; 2007 Aug; 130(4):678-90. PubMed ID: 17719545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CP110 suppresses primary cilia formation through its interaction with CEP290, a protein deficient in human ciliary disease.
    Tsang WY; Bossard C; Khanna H; Peränen J; Swaroop A; Malhotra V; Dynlacht BD
    Dev Cell; 2008 Aug; 15(2):187-97. PubMed ID: 18694559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.